Wendimagegn Alemayehu

2.6k total citations · 1 hit paper
48 papers, 1.4k citations indexed

About

Wendimagegn Alemayehu is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Wendimagegn Alemayehu has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Wendimagegn Alemayehu's work include Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (11 papers) and Acute Myocardial Infarction Research (8 papers). Wendimagegn Alemayehu is often cited by papers focused on Heart Failure Treatment and Management (17 papers), Cardiovascular Function and Risk Factors (11 papers) and Acute Myocardial Infarction Research (8 papers). Wendimagegn Alemayehu collaborates with scholars based in Canada, Netherlands and United States. Wendimagegn Alemayehu's co-authors include Shafak Aluwini, Luca Incrocci, Ben Heijmen, Floris J. Pos, Augustinus D. G. Krol, Erik C. Schimmel, Wilma D. Heemsbergen, P.P. van der Toorn, Cynthia M. Westerhout and Peter-Paul van der Toorn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Wendimagegn Alemayehu

44 papers receiving 1.3k citations

Hit Papers

Hypofractionated versus conventionally fractionated radio... 2016 2026 2019 2022 2016 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial
    2016 329 citations Luca Incrocci, Ruud C. Wortel et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendimagegn Alemayehu Canada 14 703 420 412 220 158 48 1.4k
Akihiko Matsumura Japan 17 399 0.6× 80 0.2× 528 1.3× 160 0.7× 197 1.2× 91 946
Monica Casiraghi Italy 24 1.1k 1.6× 74 0.2× 93 0.2× 299 1.4× 485 3.1× 136 1.8k
Peter Kirkbride Canada 18 621 0.9× 209 0.5× 73 0.2× 150 0.7× 793 5.0× 33 1.8k
Andrew Feifer Canada 20 577 0.8× 94 0.2× 90 0.2× 60 0.3× 505 3.2× 49 1.3k
Richard Inculet Canada 27 2.4k 3.4× 97 0.2× 169 0.4× 548 2.5× 1.3k 8.0× 99 3.3k
F. Thomas United States 14 605 0.9× 119 0.3× 74 0.2× 136 0.6× 231 1.5× 33 1.1k
Jae Ill Zo South Korea 32 2.5k 3.5× 107 0.3× 146 0.4× 539 2.5× 882 5.6× 113 3.3k
Ward V. Houck United States 14 1.0k 1.5× 27 0.1× 324 0.8× 102 0.5× 449 2.8× 22 1.5k
Howard J. Dworkin United States 18 220 0.3× 80 0.2× 101 0.2× 438 2.0× 221 1.4× 68 983
Ronald Kodama Canada 14 661 0.9× 98 0.2× 38 0.1× 89 0.4× 279 1.8× 37 1.1k

Countries citing papers authored by Wendimagegn Alemayehu

Since Specialization
Citations

This map shows the geographic impact of Wendimagegn Alemayehu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendimagegn Alemayehu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendimagegn Alemayehu more than expected).

Fields of papers citing papers by Wendimagegn Alemayehu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendimagegn Alemayehu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendimagegn Alemayehu. The network helps show where Wendimagegn Alemayehu may publish in the future.

Co-authorship network of co-authors of Wendimagegn Alemayehu

This figure shows the co-authorship network connecting the top 25 collaborators of Wendimagegn Alemayehu. A scholar is included among the top collaborators of Wendimagegn Alemayehu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendimagegn Alemayehu. Wendimagegn Alemayehu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zampieri, Fernando G., Finlay A. McAlister, Heather J. Ross, et al.. (2025). Heterogeneity in Treatment Effects in the Reduction of Dietary Sodium to Less Than 100 mmol in Heart Failure (SODIUM-HF): A Secondary Post Hoc Analysis. Journal of Cardiac Failure. 32(2). 371–381. 1 indexed citations
2.
Gouda, Pishoy, Wendimagegn Alemayehu, Adriaan A. Voors, et al.. (2025). Implantable Cardioverter-Defibrillators in Ischaemic Versus Non-Ischaemic Heart Failure: Insights from the VICTORIA Trial. European Journal of Heart Failure. 27(9). 1633–1643.
3.
Cohen‐Solal, Alain, Wendimagegn Alemayehu, Hiroyuki Tsutsui, et al.. (2025). Geographic Variation and Human Development Index in Heart Failure With Reduced Ejection Fraction. JACC Heart Failure. 13(9). 102548–102548. 1 indexed citations
4.
Westerhout, Cynthia M., Wendimagegn Alemayehu, Alain Cohen‐Solal, et al.. (2025). Geographic Region Variation in Patient Characteristics, Clinical Outcomes and Treatment of HFrEF in the VICTORIA Trial. ESC Heart Failure. 12(6). 3910–3919.
5.
deFilippi, Christopher R., Palak Shah, Sanjiv J. Shah, et al.. (2024). Proteomics Identify Clinical Phenotypes and Predict Functional Outcomes in Heart Failure With Preserved Ejection Fraction: Insights From VITALITY-HFpEF. Circulation Heart Failure. 17(9). e011792–e011792. 2 indexed citations
6.
Alemayehu, Wendimagegn, Finlay A. McAlister, Heather J. Ross, et al.. (2024). The relationship of diuretics and dietary sodium in patients with heart failure: an analysis of the SODIUM-HF trial. American Heart Journal. 281. 49–58. 1 indexed citations
7.
Saldarriaga, Clara, Eloisa Colin-Ramírez, Sunjidatul Islam, et al.. (2024). Dietary Sodium Intake and Outcomes: a Secondary Analysis From Sodium-HF. Journal of Cardiac Failure. 30(9). 1073–1082. 2 indexed citations
8.
Alemayehu, Wendimagegn, et al.. (2023). Dietary sodium intake and outcomes: a secondary analysis from SODIUM - HF. European Heart Journal. 44(Supplement_2).
9.
Colin-Ramírez, Eloisa, Wendimagegn Alemayehu, Finlay A. McAlister, et al.. (2023). The Need for ib r ddition in ymp omatic eart ailure (FEAST-HF): A Randomized Controlled Pilot Trial. CJC Open. 5(10). 760–769. 2 indexed citations
10.
deFilippi, Christopher R., Wendimagegn Alemayehu, Adriaan A. Voors, et al.. (2023). Assessment of Biomarkers of Myocardial injury, Inflammation, and Renal Function in Heart Failure With Reduced Ejection Fraction: The VICTORIA Biomarker Substudy. Journal of Cardiac Failure. 29(4). 448–458. 7 indexed citations
11.
Gouda, Pishoy, Wendimagegn Alemayehu, D. Ian Paterson, et al.. (2022). Clinical Phenotypes of Heart Failure across the spectrum of Ejection Fraction: A Cluster Analysis. Current Problems in Cardiology. 47(11). 101337–101337. 4 indexed citations
12.
Senni, Michele, Wendimagegn Alemayehu, David Sim, et al.. (2022). Efficacy and safety of vericiguat in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan: insights from the VICTORIA trial. European Journal of Heart Failure. 24(9). 1614–1622. 20 indexed citations
13.
Tsutsui, Hideki, Carolyn S.P. Lam, Dimitrios Tziakas, et al.. (2022). Geographic variation in heart failure with reduced ejection fraction: insights from the VICTORIA trial. European Heart Journal. 43(Supplement_2).
14.
Ezekowitz, Justin A., Wendimagegn Alemayehu, Andrew Grant, et al.. (2021). The Influence of Comorbidities on Achieving an N-Terminal Pro-B-Type Natriuretic Peptide Target: A Secondary Analysis of the GUIDE-IT Trial. ESC Heart Failure. 9(1). 77–86. 5 indexed citations
15.
Ponikowski, Piotr, Wendimagegn Alemayehu, Ali̇ Oto, et al.. (2021). Vericiguat in patients with atrial fibrillation and heart failure with reduced ejection fraction: insights from the VICTORIA trial. European Journal of Heart Failure. 23(8). 1300–1312. 32 indexed citations
16.
deFilippi, Christopher R., Wendimagegn Alemayehu, Adriaan A. Voors, et al.. (2021). BASELINE CARDIAC TROPONIN T, CLINICAL OUTCOMES AND VERICIGUAT TREATMENT EFFECT IN HEART FAILURE WITH REDUCED EJECTION FRACTION STUDY: INSIGHTS FROM THE VICTORIA TRIAL. Journal of the American College of Cardiology. 77(18). 565–565. 1 indexed citations
17.
Shavadia, Jay, Christopher B. Granger, Wendimagegn Alemayehu, et al.. (2019). High-throughput targeted proteomics discovery approach and spontaneous reperfusion in ST-segment elevation myocardial infarction. American Heart Journal. 220. 137–144. 8 indexed citations
18.
19.
Becher, Harald, Wendimagegn Alemayehu, D. Ian Paterson, et al.. (2018). Impact of contrast echocardiography on accurate discrimination of specific degree of left ventricular systolic dysfunction and comparison with cardiac magnetic resonance imaging. Echocardiography. 35(11). 1746–1754. 11 indexed citations
20.
Incrocci, Luca, Ruud C. Wortel, Wendimagegn Alemayehu, et al.. (2016). Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. The Lancet Oncology. 17(8). 1061–1069. 329 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiko Matsumura Breakdown of academic impact, for papers by Monica Casiraghi Breakdown of academic impact, for papers by Peter Kirkbride Breakdown of academic impact, for papers by Andrew Feifer Breakdown of academic impact, for papers by Richard Inculet Breakdown of academic impact, for papers by F. Thomas Breakdown of academic impact, for papers by Jae Ill Zo Breakdown of academic impact, for papers by Ward V. Houck Breakdown of academic impact, for papers by Howard J. Dworkin Breakdown of academic impact, for papers by Ronald Kodama
Rankless by CCL
2026